Perceptive Advisors - ACRIVON THERAPEUTICS INC ownership

ACRIVON THERAPEUTICS INC's ticker is and the CUSIP is 004890109. A total of 40 filers reported holding ACRIVON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of ACRIVON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$28,755,122
-26.2%
3,007,8580.0%0.96%
-15.0%
Q2 2023$38,981,840
+2.1%
3,007,8580.0%1.13%
+0.1%
Q1 2023$38,169,718
+10.2%
3,007,8580.0%1.13%
+15.8%
Q4 2022$34,650,5243,007,8580.97%
Other shareholders
ACRIVON THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sands Capital Ventures, LLC 1,652,605$15,798,9044.67%
Perceptive Advisors 3,007,858$28,755,1220.96%
RA Capital Management 4,810,508$45,988,4560.90%
NEA Management Company, LLC 430,252$4,113,2090.32%
DAFNA Capital Management LLC 76,852$734,7050.23%
AAF Wealth Management, LLC 10,678$102,0820.07%
UBS OCONNOR LLC 105,000$1,003,8000.02%
MARSHALL WACE, LLP 597,469$5,711,8040.01%
FEDERATED HERMES, INC. 226,375$2,164,1450.01%
EXCHANGE TRADED CONCEPTS, LLC 9,919$94,8260.00%
View complete list of ACRIVON THERAPEUTICS INC shareholders